TreeWAS – Variant ID: rs62437750

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter V Mental and behavioural disorders	1.000	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	1.000	0.000
Chapter X Diseases of the respiratory system	0.999	0.001
E10-E14 Diabetes mellitus	0.998	0.002
Chapter VIII Diseases of the ear and mastoid process	0.997	0.003
E10 Insulin-dependent diabetes mellitus	0.996	0.004
E70-E90 Metabolic disorders	0.995	0.005
Chapter VI Diseases of the nervous system	0.993	0.007
H65-H75 Diseases of middle ear and mastoid	0.991	0.009
F30-F39 Mood [affective] disorders	0.990	0.010
E10.9 Without complications	0.989	0.011
G50-G59 Nerve, nerve root and plexus disorders	0.987	0.013
E87 Other disorders of fluid, electrolyte and acid-base balance	0.985	0.015
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.983	0.017
G56 Mononeuropathies of upper limb	0.981	0.019
J09-J18 Influenza and pneumonia	0.979	0.021
G56.2 Lesion of ulnar nerve	0.978	0.022
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.977	0.023
J15 Bacterial pneumonia, not elsewhere classified	0.973	0.027
E87.1 Hypo-osmolality and hyponatraemia	0.971	0.029
J40-J47 Chronic lower respiratory diseases	0.969	0.031
J44 Other chronic obstructive pulmonary disease	0.968	0.032
F32 Depressive episode	0.964	0.036
F60-F69 Disorders of adult personality and behaviour	0.963	0.037
H66 Suppurative and unspecified otitis media	0.960	0.040
Chapter I Certain infectious and parasitic diseases	0.957	0.043
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.957	0.043
E83 Disorders of mineral metabolism	0.956	0.044
J90-J94 Other diseases of pleura	0.955	0.045
F20 Schizophrenia	0.952	0.048
G40-G47 Episodic and paroxysmal disorders	0.950	0.050
Chapter XXII Codes for special purposes	0.950	0.050
J44.8 Other specified chronic obstructive pulmonary disease	0.944	0.056
F32.9 Depressive episode, unspecified	0.939	0.061
F60 Specific personality disorders	0.936	0.064
H66.9 Otitis media, unspecified	0.936	0.064
A30-A49 Other bacterial diseases	0.935	0.065
J15.2 Pneumonia due to staphylococcus	0.930	0.070
E87.2 Acidosis	0.930	0.070
E10.3 With ophthalmic complications	0.923	0.077
Q80-Q89 Other congenital malformations	0.913	0.087
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.913	0.087
J15.1 Pneumonia due to Pseudomonas	0.911	0.089
B35-B49 Mycoses	0.911	0.089
G80-G83 Cerebral palsy and other paralytic syndromes	0.909	0.091
Chapter XX External causes of morbidity and mortality	0.906	0.094
H80-H83 Diseases of inner ear	0.906	0.094
F20.9 Schizophrenia, unspecified	0.900	0.100
Q20-Q28 Congenital malformations of the circulatory system	0.898	0.102
E83.4 Disorders of magnesium metabolism	0.897	0.103
J91 Pleural effusion in conditions classified elsewhere	0.896	0.104
F00-F09 Organic, including symptomatic, mental disorders	0.893	0.107
H74 Other disorders of middle ear and mastoid	0.886	0.114
G57 Mononeuropathies of lower limb	0.884	0.116
H73 Other disorders of tympanic membrane	0.879	0.121
A49 Bacterial infection of unspecified site	0.876	0.124
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.876	0.124
G47 Sleep disorders	0.873	0.127
E83.5 Disorders of calcium metabolism	0.872	0.128
G50 Disorders of trigeminal nerve	0.870	0.130
B37 Candidiasis	0.868	0.132
H80 Otosclerosis	0.864	0.136
F20.0 Paranoid schizophrenia	0.863	0.137
F60.3 Emotionally unstable personality disorder	0.862	0.138
U51 Admission status on psychiatric patients	0.850	0.150
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.850	0.150
G82 Paraplegia and tetraplegia	0.847	0.153
E10.5 With peripheral circulatory complications	0.846	0.154
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.843	0.157
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.838	0.162
E85 Amyloidosis	0.837	0.163
J80-J84 Other respiratory diseases principally affecting the interstitium	0.834	0.166
H80.9 Otosclerosis, unspecified	0.834	0.166
J60-J70 Lung diseases due to external agents	0.831	0.169
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.830	0.170
A48 Other bacterial diseases, not elsewhere classified	0.830	0.170
F40-F48 Neurotic, stress-related and somatoform disorders	0.819	0.181
F34 Persistent mood [affective] disorders	0.819	0.181
G44 Other headache syndromes	0.814	0.186
E11 Non-insulin-dependent diabetes mellitus	0.805	0.195
U80 Agent resistant to penicillin and related antibiotics	0.803	0.197
B37.9 Candidiasis, unspecified	0.801	0.199
H70 Mastoiditis and related conditions	0.800	0.200
Q25 Congenital malformations of great arteries	0.800	0.200
H73.8 Other specified disorders of tympanic membrane	0.799	0.201
X40-X49 Accidental poisoning by and exposure to noxious substances	0.797	0.203
F25 Schizoaffective disorders	0.794	0.205
F33 Recurrent depressive disorder	0.792	0.208
J43 Emphysema	0.791	0.209
G56.1 Other lesions of median nerve	0.789	0.211
F32.2 Severe depressive episode without psychotic symptoms	0.789	0.211
Y52 Agents primarily affecting the cardiovascular system	0.788	0.212
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.787	0.213
G56.8 Other mononeuropathies of upper limb	0.786	0.214
E40-E46 Malnutrition	0.783	0.217
J94 Other pleural conditions	0.782	0.218
G82.2 Paraplegia, unspecified	0.781	0.219
E10.8 With unspecified complications	0.780	0.220
F80-F89 Disorders of psychological development	0.779	0.221
X10-X19 Contact with heat and hot substances	0.778	0.222
G45 Transient cerebral ischaemic attacks and related syndromes	0.778	0.222
G46 Vascular syndromes of brain in cerebrovascular diseases	0.777	0.223
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.776	0.224
A49.0 Staphylococcal infection, unspecified	0.772	0.228
F03 Unspecified dementia	0.771	0.229
F31 Bipolar affective disorder	0.771	0.229
E80 Disorders of porphyrin and bilirubin metabolism	0.768	0.232
G57.6 Lesion of plantar nerve	0.766	0.234
F60.9 Personality disorder, unspecified	0.765	0.235
E87.7 Fluid overload	0.764	0.236
Q23 Congenital malformations of aortic and mitral valves	0.764	0.236
Q83 Congenital malformations of breast	0.763	0.237
J81 Pulmonary oedema	0.761	0.239
F45 Somatoform disorders	0.759	0.241
B90-B94 Sequelae of infectious and parasitic diseases	0.759	0.241
G41 Status epilepticus	0.757	0.243
E87.3 Alkalosis	0.757	0.243
U51.0 Not Previously admitted to a psyciatric hospital	0.757	0.243
A80-A89 Viral infections of the central nervous system	0.757	0.243
G83 Other paralytic syndromes	0.756	0.244
Q82 Other congenital malformations of skin	0.756	0.244
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.756	0.244
G70-G73 Diseases of myoneural junction and muscle	0.754	0.246
F39 Unspecified mood [affective] disorder	0.753	0.247
J93 Pneumothorax	0.752	0.248
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.751	0.249
G57.3 Lesion of lateral popliteal nerve	0.747	0.253
F60.7 Dependent personality disorder	0.745	0.255
A49.8 Other bacterial infections of unspecified site	0.744	0.256
F60.5 Anankastic personality disorder	0.744	0.256
B37.3 Candidiasis of vulva and vagina	0.742	0.258
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.742	0.258
G47.1 Disorders of excessive somnolence [hypersomnias]	0.742	0.258
G45.3 Amaurosis fugax	0.740	0.260
H83 Other diseases of inner ear	0.739	0.261
F60.6 Anxious [avoidant] personality disorder	0.739	0.261
Y45.1 Salicylates	0.738	0.262
G47.9 Sleep disorder, unspecified	0.738	0.262
J17 Pneumonia in diseases classified elsewhere	0.737	0.262
J90 Pleural effusion, not elsewhere classified	0.737	0.263
Y46 Antiepileptics and anti-Parkinsonism drugs	0.737	0.263
E14 Unspecified diabetes mellitus	0.736	0.264
J86 Pyothorax	0.736	0.264
F23 Acute and transient psychotic disorders	0.736	0.264
G44.2 Tension-type headache	0.735	0.265
Q85 Phakomatoses, not elsewhere classified	0.735	0.265
U51.1 Previously admitted to a psychiatric hospital of the provider	0.734	0.266
J15.4 Pneumonia due to other streptococci	0.733	0.267
G50.0 Trigeminal neuralgia	0.733	0.267
Q24 Other congenital malformations of heart	0.732	0.268
F02 Dementia in other diseases classified elsewhere	0.731	0.269
E11.3 With ophthalmic complications	0.730	0.270
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.728	0.272
A50-A64 Infections with a predominantly sexual mode of transmission	0.725	0.275
H74.4 Polyp of middle ear	0.723	0.277
W00-W19 Falls	0.722	0.278
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.721	0.279
F99-F99 Unspecified mental disorder	0.720	0.280
F30 Manic episode	0.720	0.280
E74 Other disorders of carbohydrate metabolism	0.720	0.280
F29 Unspecified nonorganic psychosis	0.719	0.281
G50.1 Atypical facial pain	0.719	0.281
Chapter XI Diseases of the digestive system	0.718	0.282
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.718	0.282
H69 Other disorders of Eustachian tube	0.718	0.282
H60-H62 Diseases of external ear	0.718	0.282
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
B35 Dermatophytosis	0.717	0.283
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.717	0.283
F70-F79 Mental retardation	0.717	0.283
E12 Malnutrition-related diabetes mellitus	0.715	0.285
Q60-Q64 Congenital malformations of the urinary system	0.715	0.285
E10.7 With multiple complications	0.714	0.286
E10.6 With other specified complications	0.714	0.286
E84 Cystic fibrosis	0.713	0.286
E79 Disorders of purine and pyrimidine metabolism	0.713	0.286
E77 Disorders of glycoprotein metabolism	0.713	0.286
E76 Disorders of glycosaminoglycan metabolism	0.713	0.286
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.713	0.286
E72 Other disorders of amino-acid metabolism	0.713	0.286
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.713	0.286
E70 Disorders of aromatic amino-acid metabolism	0.713	0.286
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.713	0.286
A39 Meningococcal infection	0.712	0.287
E10.0 With coma	0.712	0.288
J10 Influenza due to identified influenza virus	0.712	0.288
E11.6 With other specified complications	0.711	0.288
J11 Influenza, virus not identified	0.711	0.289
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.711	0.289
H68 Eustachian salpingitis and obstruction	0.711	0.289
H67 Otitis media in diseases classified elsewhere	0.711	0.289
F38 Other mood [affective] disorders	0.710	0.290
Y45.2 Propionic acid derivatives	0.709	0.291
G82.4 Spastic tetraplegia	0.709	0.291
F32.1 Moderate depressive episode	0.709	0.291
G52 Disorders of other cranial nerves	0.708	0.292
B37.4 Candidiasis of other urogenital sites	0.707	0.292
E87.0 Hyperosmolality and hypernatraemia	0.707	0.293
H66.3 Other chronic suppurative otitis media	0.707	0.293
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.707	0.293
E87.4 Mixed disorder of acid-base balance	0.706	0.294
Q89 Other congenital malformations, not elsewhere classified	0.706	0.294
A41 Other septicaemia	0.706	0.294
Q35-Q37 Cleft lip and cleft palate	0.705	0.295
Q30-Q34 Congenital malformations of the respiratory system	0.705	0.295
Y51 Drugs primarily affecting the autonomic nervous system	0.704	0.296
E85.9 Amyloidosis, unspecified	0.704	0.296
A49.1 Streptococcal infection, unspecified	0.704	0.296
G56.9 Mononeuropathy of upper limb, unspecified	0.703	0.296
G56.4 Causalgia	0.703	0.296
E86 Volume depletion	0.702	0.298
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.702	0.298
J12 Viral pneumonia, not elsewhere classified	0.702	0.298
J09 Influenza due to certain identified influenza virus	0.702	0.298
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.701	0.299
F28 Other nonorganic psychotic disorders	0.700	0.300
F24 Induced delusional disorder	0.700	0.300
F21 Schizotypal disorder	0.700	0.300
A48.1 Legionnaires' disease	0.700	0.300
H74.9 Disorder of middle ear and mastoid, unspecified	0.700	0.300
G56.3 Lesion of radial nerve	0.699	0.301
H65 Nonsuppurative otitis media	0.699	0.301
A40 Streptococcal septicaemia	0.698	0.302
E13 Other specified diabetes mellitus	0.698	0.302
B49 Unspecified mycosis	0.698	0.302
J15.9 Bacterial pneumonia, unspecified	0.697	0.302
J15.8 Other bacterial pneumonia	0.697	0.302
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.697	0.302
J15.5 Pneumonia due to Escherichia coli	0.697	0.302
J15.3 Pneumonia due to streptococcus, group B	0.697	0.302
H74.3 Other acquired abnormalities of ear ossicles	0.697	0.303
E11.9 Without complications	0.697	0.303
F34.1 Dysthymia	0.696	0.304
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.695	0.305
J00-J06 Acute upper respiratory infections	0.695	0.305
J41 Simple and mucopurulent chronic bronchitis	0.695	0.305
A48.8 Other specified bacterial diseases	0.694	0.306
B50-B64 Protozoal diseases	0.694	0.306
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.693	0.307
E10.1 With ketoacidosis	0.691	0.309
B65-B83 Helminthiases	0.691	0.309
F32.8 Other depressive episodes	0.691	0.309
F68 Other disorders of adult personality and behaviour	0.690	0.310
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.690	0.310
F65 Disorders of sexual preference	0.690	0.310
F64 Gender identity disorders	0.690	0.310
F63 Habit and impulse disorders	0.690	0.310
F62 Enduring personality changes, not attributable to brain damage and disease	0.690	0.310
F69 Unspecified disorder of adult personality and behaviour	0.690	0.310
F61 Mixed and other personality disorders	0.690	0.310
J14 Pneumonia due to Haemophilus influenzae	0.690	0.310
H66.4 Suppurative otitis media, unspecified	0.688	0.312
H66.2 Chronic atticoantral suppurative otitis media	0.688	0.312
H66.1 Chronic tubotympanic suppurative otitis media	0.688	0.312
H66.0 Acute suppurative otitis media	0.688	0.312
G00-G09 Inflammatory diseases of the central nervous system	0.687	0.313
B85-B89 Pediculosis, acariasis and other infestations	0.686	0.313
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.686	0.313
A75-A79 Rickettsioses	0.686	0.313
A70-A74 Other diseases caused by chlamydiae	0.686	0.313
A65-A69 Other spirochaetal diseases	0.686	0.313
A20-A28 Certain zoonotic bacterial diseases	0.686	0.313
A15-A19 Tuberculosis	0.686	0.313
X12 Contact with other hot fluids	0.686	0.314
E83.9 Disorder of mineral metabolism, unspecified	0.685	0.314
E83.8 Other disorders of mineral metabolism	0.685	0.314
E83.2 Disorders of zinc metabolism	0.685	0.314
E83.0 Disorders of copper metabolism	0.685	0.314
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.685	0.315
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.685	0.315
J15.0 Pneumonia due to Klebsiella pneumoniae	0.685	0.315
U80.0 Penicillin resistant agent	0.683	0.317
F20.8 Other schizophrenia	0.683	0.317
F20.6 Simple schizophrenia	0.683	0.317
F20.5 Residual schizophrenia	0.683	0.317
F20.4 Postschizophrenic depression	0.683	0.317
F20.3 Undifferentiated schizophrenia	0.683	0.317
F20.2 Catatonic schizophrenia	0.683	0.317
F20.1 Hebephrenic schizophrenia	0.683	0.317
H71 Cholesteatoma of middle ear	0.682	0.318
Y41 Other systemic anti-infectives and antiparasitics	0.682	0.318
K70-K77 Diseases of liver	0.681	0.319
Q25.1 Coarctation of aorta	0.680	0.320
K20 Oesophagitis	0.679	0.321
K20-K31 Diseases of oesophagus, stomach and duodenum	0.678	0.322
E00-E07 Disorders of thyroid gland	0.678	0.322
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.678	0.322
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.678	0.322
K70 Alcoholic liver disease	0.676	0.324
J46 Status asthmaticus	0.675	0.325
Q18 Other congenital malformations of face and neck	0.674	0.326
H72 Perforation of tympanic membrane	0.674	0.326
F01 Vascular dementia	0.674	0.326
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.673	0.327
Y49 Psychotropic drugs, not elsewhere classified	0.673	0.327
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.673	0.327
F32.0 Mild depressive episode	0.672	0.328
B99-B99 Other infectious diseases	0.671	0.328
X58-X59 Accidental exposure to other and unspecified factors	0.672	0.328
F60.8 Other specific personality disorders	0.671	0.328
F60.4 Histrionic personality disorder	0.671	0.328
F60.2 Dissocial personality disorder	0.671	0.328
F60.1 Schizoid personality disorder	0.671	0.328
F60.0 Paranoid personality disorder	0.671	0.328
A44 Bartonellosis	0.670	0.330
A43 Nocardiosis	0.670	0.330
A42 Actinomycosis	0.670	0.330
A37 Whooping cough	0.670	0.330
A36 Diphtheria	0.670	0.330
A32 Listeriosis	0.670	0.330
A31 Infection due to other mycobacteria	0.670	0.330
A30 Leprosy [Hansen's disease]	0.670	0.330
A38 Scarlet fever	0.670	0.330
A35 Other tetanus	0.670	0.330
A34 Obstetrical tetanus	0.670	0.330
A33 Tetanus neonatorum	0.670	0.330
G47.4 Narcolepsy and cataplexy	0.670	0.330
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.670	0.330
B37.2 Candidiasis of skin and nail	0.670	0.330
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.670	0.330
Q28 Other congenital malformations of circulatory system	0.669	0.331
E10.2 With renal complications	0.667	0.333
K35-K38 Diseases of appendix	0.667	0.333
E83.1 Disorders of iron metabolism	0.667	0.333
Y45.8 Other analgesics and antipyretics	0.667	0.333
Q25.6 Stenosis of pulmonary artery	0.666	0.334
H90-H95 Other disorders of ear	0.666	0.334
Q50-Q56 Congenital malformations of genital organs	0.663	0.337
K70.9 Alcoholic liver disease, unspecified	0.663	0.337
H74.8 Other specified disorders of middle ear and mastoid	0.662	0.338
X41.9 Unspecified place	0.662	0.338
J43.9 Emphysema, unspecified	0.662	0.338
X50-X57 Overexertion, travel and privation	0.661	0.339
J86.9 Pyothorax without fistula	0.661	0.339
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.661	0.339
J93.1 Other spontaneous pneumothorax	0.660	0.340
Y53 Agents primarily affecting the gastro-intestinal system	0.658	0.342
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.658	0.342
G55.2 Nerve root and plexus compressions in spondylosis	0.657	0.343
G44.4 Drug-induced headache, not elsewhere classified	0.657	0.343
Y52.4 Angiotensin-converting-enzyme inhibitors	0.655	0.345
Q83.8 Other congenital malformations of breast	0.655	0.345
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.655	0.345
Q84 Other congenital malformations of integument	0.655	0.345
Q81 Epidermolysis bullosa	0.655	0.345
Q80 Congenital ichthyosis	0.655	0.345
U81 Agent resistant to vancomycin and related antibiotics	0.654	0.345
U50 Level of care administered to neonates	0.654	0.345
U07 Emergency use of U07	0.654	0.345
U06 Emergency use of U06	0.654	0.345
U04 Severe acute respiratory syndrome [SARS]	0.654	0.345
U52 First in a series of a regular day/night admissions	0.654	0.345
E88 Other metabolic disorders	0.654	0.346
J82 Pulmonary eosinophilia, not elsewhere classified	0.653	0.347
G46.7 Other lacunar syndromes	0.653	0.347
B48 Other mycoses, not elsewhere classified	0.653	0.347
B47 Mycetoma	0.653	0.347
B46 Zygomycosis	0.653	0.347
B45 Cryptococcosis	0.653	0.347
B43 Chromomycosis and phaeomycotic abscess	0.653	0.347
B42 Sporotrichosis	0.653	0.347
B41 Paracoccidioidomycosis	0.653	0.347
B40 Blastomycosis	0.653	0.347
B39 Histoplasmosis	0.653	0.347
B38 Coccidioidomycosis	0.653	0.347
B36 Other superficial mycoses	0.653	0.347
H74.0 Tympanosclerosis	0.652	0.348
F45.0 Somatisation disorder	0.652	0.348
V10-V19 Pedal cyclist injured in transport accident	0.652	0.348
A46 Erysipelas	0.651	0.349
Q12 Congenital lens malformations	0.651	0.349
E85.3 Secondary systemic amyloidosis	0.651	0.349
Q23.1 Congenital insufficiency of aortic valve	0.650	0.350
Y35-Y36 Legal intervention and operations of war	0.650	0.350
Y10-Y34 Event of undetermined intent	0.650	0.350
X85-X99 Assault	0.650	0.350
X30-X39 Exposure to forces of nature	0.650	0.350
X00-X09 Exposure to smoke, fire and flames	0.650	0.350
W75-W84 Other accidental threats to breathing	0.650	0.350
W65-W74 Accidental drowning and submersion	0.650	0.350
V98-V99 Other and unspecified transport accidents	0.650	0.350
V95-V97 Air and space transport accidents	0.650	0.350
V90-V94 Water transport accidents	0.650	0.350
V70-V79 Bus occupant injured in transport accident	0.650	0.350
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.650	0.350
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.650	0.350
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.650	0.350
V01-V09 Pedestrian injured in transport accident	0.650	0.350
H82 Vertiginous syndromes in diseases classified elsewhere	0.650	0.350
K35 Acute appendicitis	0.649	0.351
H70.8 Other mastoiditis and related conditions	0.649	0.351
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit	0.648	0.352
G57.8 Other mononeuropathies of lower limb	0.648	0.352
G54 Nerve root and plexus disorders	0.647	0.353
F32.3 Severe depressive episode with psychotic symptoms	0.646	0.354
Y00-Y09 Assault	0.645	0.355
Q26 Congenital malformations of great veins	0.644	0.356
Q22 Congenital malformations of pulmonary and tricuspid valves	0.644	0.356
Q20 Congenital malformations of cardiac chambers and connexions	0.644	0.356
K35.9 Acute appendicitis, unspecified	0.644	0.356
F45.3 Somatoform autonomic dysfunction	0.643	0.357
B37.1 Pulmonary candidiasis	0.643	0.357
F09 Unspecified organic or symptomatic mental disorder	0.641	0.359
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.641	0.359
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.640	0.360
G47.3 Sleep apnoea	0.638	0.362
Q78 Other osteochondrodysplasias	0.636	0.363
Q82.5 Congenital nonneoplastic naevus	0.635	0.365
H74.2 Discontinuity and dislocation of ear ossicles	0.635	0.365
H74.1 Adhesive middle ear disease	0.635	0.365
F43 Reaction to severe stress, and adjustment disorders	0.634	0.365
G57.9 Mononeuropathy of lower limb, unspecified	0.634	0.366
G57.5 Tarsal tunnel syndrome	0.634	0.366
G57.4 Lesion of medial popliteal nerve	0.634	0.366
G57.2 Lesion of femoral nerve	0.634	0.366
G57.0 Lesion of sciatic nerve	0.634	0.366
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.634	0.366
B15-B19 Viral hepatitis	0.632	0.368
F25.1 Schizoaffective disorder, depressive type	0.631	0.369
H73.9 Disorder of tympanic membrane, unspecified	0.630	0.369
H73.1 Chronic myringitis	0.630	0.369
H73.0 Acute myringitis	0.630	0.369
F22 Persistent delusional disorders	0.630	0.370
A49.3 Mycoplasma infection, unspecified	0.628	0.372
A49.2 Haemophilus influenzae infection, unspecified	0.628	0.372
Y59 Other and unspecified vaccines and biological substances	0.628	0.372
Y58 Bacterial vaccines	0.628	0.372
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.628	0.372
Y50 Central nervous system stimulants, not elsewhere classified	0.628	0.372
Y47 Sedatives, hypnotics and antianxiety drugs	0.628	0.372
E46 Unspecified protein-energy malnutrition	0.628	0.372
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified	0.627	0.373
W17 Other fall from one level to another	0.627	0.373
G47.2 Disorders of the sleep-wake schedule	0.626	0.374
J40 Bronchitis, not specified as acute or chronic	0.626	0.374
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.626	0.374
E87.5 Hyperkalaemia	0.625	0.375
G83.4 Cauda equina syndrome	0.624	0.375
G50.9 Disorder of trigeminal nerve, unspecified	0.624	0.376
G50.8 Other disorders of trigeminal nerve	0.624	0.376
U80.1 Methicillin resistant agent	0.624	0.376
J85 Abscess of lung and mediastinum	0.623	0.377
B37.7 Candidal septicaemia	0.622	0.378
B37.6 Candidal endocarditis	0.622	0.378
B37.5 Candidal meningitis	0.622	0.378
V40-V49 Car occupant injured in transport accident	0.622	0.378
K90-K93 Other diseases of the digestive system	0.621	0.379
X12.0 Home	0.621	0.379
Y52.3 Coronary vasodilators, not elsewhere classified	0.619	0.381
H80.8 Other otosclerosis	0.619	0.381
H80.2 Cochlear otosclerosis	0.619	0.381
H80.1 Otosclerosis involving oval window, obliterative	0.619	0.381
H80.0 Otosclerosis involving oval window, nonobliterative	0.619	0.381
G41.9 Status epilepticus, unspecified	0.619	0.381
Y54.3 Benzothiadiazine derivatives	0.616	0.383
B91 Sequelae of poliomyelitis	0.616	0.383
G53 Cranial nerve disorders in diseases classified elsewhere	0.616	0.384
J18 Pneumonia, organism unspecified	0.616	0.384
F25.9 Schizoaffective disorder, unspecified	0.615	0.385
X45 Accidental poisoning by and exposure to alcohol	0.615	0.385
A41.0 Septicaemia due to Staphylococcus aureus	0.615	0.385
B20-B24 Human immunodeficiency virus [HIV] disease	0.614	0.386
A41.5 Septicaemia due to other Gram-negative organisms	0.613	0.387
U80.8 Agent resistant to other penicillin-related antibiotic	0.613	0.387
W50-W64 Exposure to animate mechanical forces	0.612	0.388
V20-V29 Motorcycle rider injured in transport accident	0.612	0.388
J20-J22 Other acute lower respiratory infections	0.611	0.389
A86 Unspecified viral encephalitis	0.611	0.389
G82.5 Tetraplegia, unspecified	0.611	0.389
J94.8 Other specified pleural conditions	0.610	0.390
K90 Intestinal malabsorption	0.610	0.390
A60 Anogenital herpesviral [herpes simplex] infections	0.610	0.390
U51.2 Previously admitted to a psychiatric hospital of another provider	0.609	0.390
F48 Other neurotic disorders	0.609	0.391
G82.3 Flaccid tetraplegia	0.607	0.393
G82.0 Flaccid paraplegia	0.607	0.393
Q85.0 Neurofibromatosis (nonmalignant)	0.607	0.393
Q00-Q07 Congenital malformations of the nervous system	0.606	0.394
E80.4 Gilbert's syndrome	0.606	0.394
J80 Adult respiratory distress syndrome	0.606	0.394
X47 Accidental poisoning by and exposure to other gases and vapours	0.605	0.394
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.604	0.395
Y45.5 4-Aminophenol derivatives	0.604	0.395
Y45.4 Antirheumatics	0.604	0.395
A49.9 Bacterial infection, unspecified	0.604	0.396
K26 Duodenal ulcer	0.603	0.397
Y52.1 Calcium-channel blockers	0.602	0.398
F31.6 Bipolar affective disorder, current episode mixed	0.602	0.398
J69 Pneumonitis due to solids and liquids	0.602	0.398
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.602	0.398
Q17 Other congenital malformations of ear	0.601	0.399
Q16 Congenital malformations of ear causing impairment of hearing	0.601	0.399
Q15 Other congenital malformations of eye	0.601	0.399
Q14 Congenital malformations of posterior segment of eye	0.601	0.399
Q13 Congenital malformations of anterior segment of eye	0.601	0.399
Q11 Anophthalmos, microphthalmos and macrophthalmos	0.601	0.399
F45.8 Other somatoform disorders	0.601	0.399
H90 Conductive and sensorineural hearing loss	0.600	0.400
E85.8 Other amyloidosis	0.600	0.400

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations